Publication | Closed Access

Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis

PsychoneuroimmunologyNeuropsychologyAutoimmune DiseaseBehavioral NeuroscienceMedicineHistopathological DeficitsExperimental Autoimmune EncephalomyelitisDark AgoutiAutoimmunityBrain-immune InteractionNeurologyBiological PsychiatryNeuroscienceNeuroimmunologySocial Sciences